Plain-English translation of NCT06390956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications— and —work together to treat marginal zone lymphoma in newly diagnosed patients. Marginal zone lymphoma is a type of blood cancer that grows slowly. Researchers want to learn if this combination can help patients achieve remission (where the cancer disappears or shrinks significantly).
Marginal zone lymphoma is a rare cancer, and doctors want to find the most effective treatment options for patients who have just been diagnosed. This trial is designed to see whether this specific combination of medications is better at fighting the disease than what is currently available.
You likely qualify if…
You likely don't qualify if…
You would receive the two medications together for the first 6 cycles (about 42 days each cycle). If your cancer responds well and disappears completely, you would continue with one medication alone for 6 more cycles. If your cancer only partially shrinks or stays stable, you would continue both medications for additional cycles. Throughout the trial, you would have regular visits to check your blood work and overall health, and researchers would follow up with you after treatment ends.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Phase
Testing effectiveness
Sponsor
University of Utah
Collaborators
Eli Lilly and Company
Enrollment target
~23 participants
Started
February 2025
Primary completion
December 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rachel Kingsford
University of Utah
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.